Table 3.
Number of participants | ||
Age group | ||
18–29 years | 1 | |
30–39 years | 5 | |
40–49 years | 8 | |
50–59 years | 14 | |
60 years and over | 8 | |
Sex | ||
Male | 13 | |
Female | 23 | |
Stakeholder group | ||
Rheumatologist | 8 | |
Patient | 6 | |
Government advisor | 5 | |
Public servant | 8 | |
Consumer representative | 5 | |
Pharmaceutical industry representative | 3 | |
Clinical nurse | 1 |